Buying Cures vs. Renting Health: How Financial Engineering Can Expedite Medical Breakthroughs

Using securitization, credit default swaps, and other standard tools of the financial industry, Andrew Lo proposes a path to reinvent the biopharma industry to yield many more transformative therapies at lower cost, lower risk, and in less time.